Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock, $0.001 par value per share · CUSIP: 34962G208
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Boothbay Fund Management, LLC
Shares: 88,785.00 · Class: 6%
- Ari Glass
Shares: 88,785.00 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006295
- Form type
- SCHEDULE 13G
- Filer
- BOOTHBAY FUND MANAGEMENT, LLC
- CIK
- CIK 1549230
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership